Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine

The leading malaria vaccine in development is the circumsporozoite (CS) protein-based vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy largely mediated by CS specific antibodies. We aimed to enhance vaccine e...

Bibliografske podrobnosti
Main Authors:	Gilbert, S, Collins, K, Snaith, R, Cottingham, M, Hill, A
Format:	Journal article
Izdano:	Nature Publishing Group 2017

Podobne knjige/članki

Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity
od: Chauveau, L, et al.
Izdano: (2021)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
od: Jerri C. Caldeira, et al.
Izdano: (2020-04-01)

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
od: Jo-Anne Chan, et al.
Izdano: (2019-01-01)

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.
od: Schneider, J, et al.
Izdano: (1998)

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice
od: Katharine A. Collins, et al.
Izdano: (2021-05-01)

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.
od: Dégano, P, et al.
Izdano: (1999)

Protein particle vaccines against malaria.
od: Gilbert, S, et al.
Izdano: (1997)

Virus-like particles as vaccine adjuvants.
od: Gilbert, S
Izdano: (2001)

Virus-like particle vaccines
od: Mukhopadhyay, E, et al.
Izdano: (2022)

Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease
od: Bennett J. Davenport, et al.
Izdano: (2022-05-01)

Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
od: Moorthy, V, et al.
Izdano: (2003)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
od: Hyeon-Jeong Go, et al.
Izdano: (2021-11-01)

Virus-like Particle Vaccines of Infectious Bursal Disease Virus Expressed in <i>Escherichia coli</i> Are Highly Immunogenic and Protect against Virulent Strain
od: Pengchao Ji, et al.
Izdano: (2023-10-01)

Immunization with Virus-Like Particle Vaccine Protects Rabbits against Hepatitis E-3 Virus Infection
od: Hyeon-Jeong Go, et al.
Izdano: (2022-06-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
od: Dicks, M, et al.
Izdano: (2011)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
od: Mcshane, H, et al.
Izdano: (2001)

Immunogenicity and protective efficacy of a novel bacterium-like particle-based vaccine displaying canine distemper virus antigens in mice and dogs
od: Jianzhong Wang, et al.
Izdano: (2024-04-01)

Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine.
od: Erin M Jackson, et al.
Izdano: (2012-01-01)

Complete protective immunity against blood-stage malaria induced by heterologous prime-boost vaccination
od: Draper, S, et al.
Izdano: (2005)

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
od: Draper, S, et al.
Izdano: (2010)

The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus.
od: de Cassan, S, et al.
Izdano: (2011)

Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving T and B cell immunogenicity and protection against Plasmodium berghei/vivax
od: Cabral-Miranda, G, et al.
Izdano: (2017)

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
od: Gustavo Cabral-Miranda, et al.
Izdano: (2017-05-01)

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.
od: Gilbert, S, et al.
Izdano: (2002)

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
od: Ambühl, P, et al.
Izdano: (2007)

A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine
od: Dan Xu, et al.
Izdano: (2024-11-01)

Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens
od: Celia Abolnik, et al.
Izdano: (2022-06-01)

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.
od: Gilbert, S, et al.
Izdano: (1999)

Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.
od: Irina Margine, et al.
Izdano: (2012-01-01)

Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles
od: Lin-Feng Cheng, et al.
Izdano: (2016-12-01)

Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice
od: Fenlian Ma, et al.
Izdano: (2023-10-01)

Potent Protective Immune Responses to <i>Senecavirus</i> Induced by Virus-Like Particle Vaccine in Pigs
od: Suyu Mu, et al.
Izdano: (2020-09-01)

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.
od: Moore, A, et al.
Izdano: (2005)

Immunogenicity of vaccines for malaria-exposed populations
od: Bowyer, GSA
Izdano: (2018)

Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
od: Saghi Nooraei, et al.
Izdano: (2021-02-01)

Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease
od: Yoichi Nakahira, et al.
Izdano: (2021-08-01)

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
od: Spencer, A, et al.
Izdano: (2014)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
od: Katrin Kramer, et al.
Izdano: (2019-01-01)

Uncovering the mechanisms of adenovirus vector immunogenicity
od: Dicks, M, et al.
Izdano: (2013)

Heterologous vaccine immunogenicity, efficacy, and immune correlates of protection of a modified-live virus porcine reproductive and respiratory syndrome virus vaccine
od: Jessica Proctor, et al.
Izdano: (2022-09-01)